drugset / Trial / NCT01936285

Colchicine in ST-elevation Myocardial Infarction

NCT01936285

Phase 4 Unknown 150 enrolled G.Gennimatas General Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

* There is evidence that inflammatory processes may play detrimental role during the acute phase of myocardial infarction * The hypothesis of this study is that colchicine, by its anti-inflammatory action, may lead to reduction in infarct size, when administered during the acute phase of myocardial infarction

Timeline

Start
2013-07
Primary completion
2015-04
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Colchicine Small molecule 0.5 mg